Skip to content

In the BioHarmony Drug Report Database


Teysuno (gimeracil) is a small molecule pharmaceutical. Gimeracil was first approved as Teysuno on 2011-03-14. It has been approved in Europe to treat stomach neoplasms.
Trade Name Teysuno
Common Name Gimeracil
Indication stomach neoplasms
Drug Class Uracil type antineoplastics
Get full access now